Keywords: watson, offers, million, circa, us-based, generic, drugmaker

Watson Offers $606.5 Million For Circa

Article | 10 April 1995

Print This

US-based generic drugmaker Watson has made a $606.5 million offer to acquire Circa (formerly Bolar Pharmaceuticals), the main asset of which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in